for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inspire Medical Systems Inc

INSP.N

Latest Trade

221.33USD

Change

-2.20(-0.98%)

Volume

50,760

Today's Range

220.54

 - 

228.53

52 Week Range

40.56

 - 

228.53

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Inspire Medical Systems Posts Q3 Loss Per Share Of $0.39

Nov 2 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS AND UPDATES 2020 OUTLOOK.Q3 LOSS PER SHARE $0.39.Q3 EARNINGS PER SHARE ESTIMATE $-0.72 -- REFINITIV IBES DATA.INCREASING ITS FULL YEAR 2020 REVENUE GUIDANCE TO BETWEEN $110 MILLION AND $112 MILLION.AS OF SEPTEMBER 30, 2020, CASH, CASH EQUIVALENTS AND INVESTMENTS WERE $234.6 MILLION.

Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial Results And Updates 2020 Outlook

Aug 4 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND UPDATES 2020 OUTLOOK.Q2 LOSS PER SHARE $0.88.Q2 REVENUE FELL 32 PERCENT TO $12.2 MILLION.SEES FY 2020 REVENUE UP ABOUT 7 TO 12 PERCENT.SEES FY 2020 REVENUE $88 MILLION TO $92 MILLION.Q2 REVENUE ESTIMATE $7.9 MILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE ESTIMATE $-1.10 -- REFINITIV IBES DATA.EXPECTS TO ADD 20 TO 24 NEW U.S. IMPLANTING CENTERS AND SIX TO SEVEN NEW TERRITORIES PER QUARTER FOR REMAINDER OF 2020.FY2020 REVENUE VIEW $78.5 MILLION -- REFINITIV IBES DATA.

Inspire Medical Systems Q1 Loss Per Share $0.67

May 5 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.67.Q1 REVENUE $21.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $21.3 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.57 -- REFINITIV IBES DATA.

Inspire Medical Systems Gets FDA Approval Of Expanded Age Range For Inspire Therapy

April 21 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS ANNOUNCES FDA APPROVAL OF EXPANDED AGE RANGE FOR INSPIRE THERAPY.INSPIRE MEDICAL SYSTEMS - FDA HAS APPROVED AN EXPANDED AGE RANGE FOR INSPIRE THERAPY TO INCLUDE 18-21 YEAR OLD PATIENTS.

Inspire Medical Systems Prices Offering Of 2 Mln Common Shares At $58/Shr

April 13 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES PRICING OF OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.00 MILLION COMMON SHARES PRICED AT $58.00PER SHARE.

Inspire Medical Systems Inc Reports Proposed Offering Of Common Stock

April 13 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.INSPIRE MEDICAL SYSTEMS - ANNOUNCED COMMENCEMENT OF PROPOSED PUBLIC OFFERING OF $75.0 MILLION OF SHARES OF COMMON STOCK.

Inspire Medical Systems Sees Q1 2020 Revenue Up 31 Percent

April 13 (Reuters) - Inspire Medical Systems Inc <INSP.N>::SEES Q1 2020 REVENUE ABOUT $21.3 MILLION.SEES Q1 2020 REVENUE UP 31 PERCENT.INSPIRE MEDICAL SYSTEMS - PRELIMINARY UNAUDITED Q1 REVENUE EXPECTED TO BE APPROXIMATELY $21.3 MILLION, A 31% INCREASE FROM $16.3 MILLION.INSPIRE MEDICAL SYSTEMS - PRELIMINARY UNAUDITED Q1 U.S. REVENUE IS EXPECTED TO BE ABOUT $19.3 MILLION, UP 34% OVER CORRESPONDING PERIOD IN PRIOR YEAR.SUBSTANTIALLY ALL OF OUR INSPIRE THERAPY PROCEDURES WERE POSTPONED BEGINNING IN SECOND WEEK OF MARCH.AS OF MARCH 31, 2020, INSPIRE HAD APPROXIMATELY $142 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS.WITHDRAWING ITS PREVIOUSLY ANNOUNCED FULL YEAR 2020 FINANCIAL GUIDANCE.

Inspire Medical Systems Q3 Loss Per Share $0.34

Nov 5 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS AND INCREASES 2019 OUTLOOK.Q3 LOSS PER SHARE $0.34.Q3 REVENUE $20.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $19.2 MILLION.SEES FY 2019 REVENUE UP ABOUT 54 TO 56 PERCENT.SEES FY 2019 REVENUE $78 MILLION TO $79 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $75.3 MILLION -- REFINITIV IBES DATA.INSPIRE INCREASED ITS GUIDANCE ON OPENING NEW U.S. MEDICAL CENTERS TO A RANGE OF 15 TO 17 IN Q4.INSPIRE MAINTAINS ITS GUIDANCE OF ADDING FOUR TO FIVE NEW TERRITORIES IN Q4.

Inspire Medical Systems Inc Reports Q2 2019 Results

Aug 6 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS AND INCREASES 2019 OUTLOOK.Q2 LOSS PER SHARE $0.32.Q2 REVENUE $18 MILLION VERSUS REFINITIV IBES ESTIMATE OF $16.7 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.43 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE UP ABOUT 44 TO 48 PERCENT.SEES FY 2019 REVENUE $73 MILLION TO $75 MILLION.GROSS MARGIN FOR FULL YEAR 2019 IS NOW EXPECTED TO BE IN RANGE OF 81% TO 83%.INSPIRE MEDICAL SYSTEMS - CONTINUES TO EXPECT TO ADD 12 TO 14 NEW U.S. IMPLANTING CENTERS AND FOUR TO FIVE NEW TERRITORY MANAGERS PER QUARTER IN 2019.FY2019 REVENUE VIEW $72.6 MILLION -- REFINITIV IBES DATA.

Inspire Medical Systems, Inc. Announces Changes To Its Board Of Directors

July 25 (Reuters) - Inspire Medical Systems Inc <INSP.N>::INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS.INSPIRE MEDICAL SYSTEMS - GARY L. ELLIS, FORMER CFO OF MEDTRONIC, WILL BE JOINING INSPIRE BOARD OF DIRECTORS, EFFECTIVE IMMEDIATELY.INSPIRE MEDICAL SYSTEMS- JOYCE ERONY, MANAGING PARTNER OF AMZAK HEALTH, WILL BE STEPPING DOWN FROM INSPIRE'S BOARD OF DIRECTORS, EFFECTIVE AUGUST 1.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up